Correspondingly, administration of the AKT inhibitor MK2206 or rapamycin impaired the invasion and stem-like phenotype of NPC cells by blocking the effects of EpCAM [15]. The gene discussed is AKT1; the disease is nasopharyngeal carcinoma.